Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (4)
  • 2022 (6)
  • 2021 (2)

Subject

  • Drug Trafficking (19)
  • HIDTA (12)
  • Task Forces/Task Force Officers (10)
  • Guilty Plea (9)
  • Guns/Weapons (6)
  • Pharmaceuticals/Pharmacists/Physicians (6)
  • Prescription Drugs (6)
  • Money Laundering (5)
  • Synthetic drugs (5)
  • OCDETF/Task Force (4)
  • Seizures (Drugs/Property) (4)
  • Fake Pills (3)
  • Major Law Enforcement Operation (3)
  • Press Conferences (3)
  • Take Back Day (3)
  • International/Foreign Operations (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Dark Web- Internet Trafficking (1)
  • Extraditions (1)
  • Gangs (1)
  • Intergovernmental Affairs (1)
  • Outreach/Drug Prevention (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Diversion Division (6)

Drug Name

  • Oxycodone (1)

Field Division

  • New England (9)
  • Washington, DC (9)
  • New York (7)
  • Chicago (5)
  • Seattle (5)
  • El Paso (4)
  • Atlanta (2)
  • Miami (2)
  • Dallas (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • San Francisco (1)
  • New Jersey (6)
Clear All Results
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

Diciembre 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
Diciembre 29, 2022
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

Agosto 03, 2022
NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
Agosto 03, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

Junio 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
Junio 28, 2022
PRESS RELEASE

Former Mercer County Pharmacist Charged with Illegally Distributing Oxycodone and Other Opiates from Trenton Pharmacy

Mayo 12, 2022
TRENTON, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former pharmacist was arrested today for her role in distributing and dispensing outside the course of professional practice...
Mayo 12, 2022
PRESS RELEASE

Mercer County Accounting Professor Charged with Tax Evasion and Filing False Tax Returns

Mayo 12, 2022
TRENTON, N.J. – A Mercer County, New Jersey, man was arrested today for tax evasion and filing false tax returns, U.S. Attorney Philip R. Sellinger announced. Gordian A. Ndubizu, 67, of Princeton Junction, New Jersey, is charged in an eight-count indictment unsealed today with four counts of tax evasion and...
Mayo 12, 2022
PRESS RELEASE

New Jersey Doctor Charged with 34 Counts of Unlawful Distribution of Controlled Substances

Febrero 09, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Passaic County, New Jersey, doctor was charged today with multiple counts of illegally prescribing medicines to his patients...
Febrero 09, 2022
Showing 1 - 6 of 6 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster